Current Studies
The Office of Research has been involved with a variety of inpatient and outpatient studies since our office was established nearly 15 years ago. Many of the drugs and devices we have studied have received FDA approval.
Here are a few examples of our successes:
Havrix™, dabigatran, alvimopan, micafungin, cinacalcet, omalizumab, dimethyl fumarate, telavancin, everolimus, methylnaltrexone, RotaTeq™, Endurant Endograft Stent™
All studies help answer an important clinical question and help lead us down the path to improved healthcare for the people of Iowa. We focus on two primary areas of research that include Clinical Trials and Investigator-Initiated Research.
Here is a listing of our current and upcoming clinical trials:
| Type of Study |
Problem |
Physician |
Phase 3 Drug
|
Functional constipation in ages 6-18 |
Dr. Manini |
| Phase 3 Drug |
Bacteremia |
Dr. Harvey |
| Phase 3 Drug |
Prevention of venous thromboembolism |
Dr. Lovell |
| Phase 3 Drug |
Migraine Prevention |
Dr. Rankin |
| Device |
Lesions in the superficial femoral artery and proximal popliteal |
Dr. Scott |
| Device |
Treatment of below-the-knee (BTK) arteries |
Dr. Scott |
| Device |
Peripheral arterial disease (PAD) |
Dr. Fry |
| Device |
Drug coated vs. standard balloon angioplasty |
Dr. Fry |
| Device |
Abdominal aortic aneurysm |
Dr. Fry |
| Device |
Femoral artery or popliteal lesions |
Dr. Fry |
| Device |
Occlusion of common and external iliac arteries |
Dr. Fry |
| Registry |
Adult kidney transplant recipients treated with specific drug |
Dr. Shadur |
| Registry |
Specific non-responder heart failure subjects |
Dr. Palakurthy |
| Registry |
Multiple Sclerosis |
Dr. Janus |
| Registry |
Endovascular abdominal aortic aneurysms |
Dr. Scott |
We currently have investigator-initiated research projects involving patient mobility, sleep apnea, behavioral health and a variety of projects with the trauma department.
For more information, please call 515-241-6727.